Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.41 |
| ▸ | F13A1 | P00488 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.41 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.39 |
| ▸ | LTB4R | Q15722 | 5/20 | 0.39 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.37 |
| ▸ | DRD3 | P35462 | 1/20 | 0.37 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24650333 | 0.96 | S1PR5 (0.44) | S1PR5F13A1MAPTRXFP1TBXA2R | |
| SCHEMBL24650341 | 0.84 | CYP4F2 (0.39) | DRD2DRD3 | |
| SCHEMBL24650329 | 0.80 | DRD2 (0.38) | MAPTDRD2DRD3 | |
| SCHEMBL24650946 | 0.80 | F13A1 (0.42) | F13A1MAPTRXFP1LTB4RTBXAS1 | |
| SCHEMBL24650934 | 0.80 | F13A1 (0.43) | F13A1MAPTRXFP1LTB4RDRD2 | |
| SCHEMBL24650352 | 0.78 | CYP4F2 (0.49) | TBXAS1DRD2 | |
| SCHEMBL526993 | 0.78 | TBXA2R (0.55) | S1PR5TBXA2RDRD2DRD3 | |
| SCHEMBL30961658 | 0.77 | PNMT (0.54) | S1PR5F13A1MAPTRXFP1LTB4R | |
| SCHEMBL24650952 | 0.77 | SLC22A12 (0.36) | F13A1MAPTRXFP1TBXAS1DRD2 | |
| SCHEMBL24650298 | 0.77 | DRD2 (0.40) | TBXA2RDRD2DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022238507-A1 | THERAPEUTIC AMINOINDANE COMPOUNDS AND COMPOSITIONS | AWAKN LS EUROPE HOLDINGS LIMITED (IE) | 2022-11-17 | — | — | WO | disclosed |